*Corresponding author:Maxim Belotserkovskiy, Department of Medical Affairs Division, Germany
Received: October 11, 2018; Published: October 24, 2018
To view the Full Article Peer-reviewed Article PDF
Multiple sclerosis is an inflammatory disease attacking the central nervous system, with a slightly reduced life-expectancy, affecting 2.1 million people worldwide, with female prevalence. A retrospective analysis summarizes safety data from 11 completed clinical trials with an aim to give an overview about Serious Adverse Event occurrence in study subjects, also detailing the events according to System Organ Class.
Keywords :SAE: Serious Adverse Event; MedDRA: Medical Dictionary for Regulatory Activities; SOC: System Organ Class; IMP: Investigational Medicinal Product; AEs: Adverse Events